>US Stocks>Endovia Health Sciences

Endovia Health SciencesHealthcare

$0.16$-0.94 (-85.18%)in 1 year

As on 13 Nov 2026 at 02:29NYSE

Endovia Health Sciences Share Price Today

Endovia Health Sciences opened lower at $0.17, compared with its previous close of $0.17. In the last trading session, the stock traded between $0.16 and $0.17. It showed a downward intraday trend.

Return calculator

You have invested

Time Period

An investment of $100 made 5 years ago in Endovia Health Sciences is now worth

$ 0.22

Resulting in a loss of

$ 99.78 (99.78%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

No analyst rating data available.

Markets Today

Today's Change

$-0.01 (-6.05%)

Day High

$0.17

Day Low

$0.16

Day Open

$0.17

Prev Close

$0.17

Volume

5,25,733

1W Return

-12.37%

1M Return

11.64%

3M Return

-52.89%

6M Return

-35.57%

1Y Return

-85.18%

Fundamentals

Market Cap ($ Mn)

PE Ratio

PB Ratio

PEG Ratio

ROE

ROCE

292.33%

EPS (TTM)

$-1.20

Investment Returns

1 Week

-12.37%

1 Month

11.64%

3 Months

-52.89%

6 Months

-35.57%

9 Months

-58.89%

Financials

Quarterly

All values in $ Mn

0.6

Dec 24

0.4

Mar 25

0.0

Jun 25

0.0

Sep 25

0.0

Dec 25

0.0

Mar 26

Updates

5Oct

Endovia CannEpil gains FDA minor use status for canine pain

FDA Center for Veterinary Medicine determined CannEpil qualifies as a minor use drug. Eligibility established for conditional approval pathway under MUMS program. Pre-Submission Conference with FDA scheduled for November 19, 2026. Companies targeting potential commercial launch for veterinary use in 2027.

1mo ago

Similar Stocks

Stock	LTP	Change %	Market Cap	PE
V Vertex Pharmaceuticals	$547.03	-0.16%	$1,38,692.89M	31.55
B British American Tobacco	$61.05	+0.38%	$1,31,510.31M	14.39
M Moderna	$248.69	-0.85%	$1,00,625.20M	-
R Regeneron Pharmaceuticals	$959.41	+4.73%	$97,505.80M	19.64
A Argen X SE - ADR	$977.58	+0.62%	$61,476.10M	38.99
O BeOne Medicines - ADR	$419.98	-0.95%	$46,108.31M	65.60
R Revolution Medicines	$180.70	-6.40%	$39,083.96M	-
G Genmab	$53.87	-0.37%	$33,618.11M	26.24
R Royalty Pharma - Class A	$70.01	+0.81%	$31,173.07M	32.37
R Roivant Sciences	$41.85	+1.60%	$30,322.88M	-
I Insmed	$120.75	+1.05%	$26,490.14M	-
I Incyte	$122.27	+1.64%	$24,922.54M	15.85